The inhibition of cationic myotropic drugs by compounds 48/80 and 46/108.
D000109:Acetylcholine / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001464:Barium / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology*; D004336:Drug Antagonism; D005260:Female; D009119:Muscle Contraction / Q000187:drug effects*; D010121:Oxytocin / Q000494:pharmacology*; D011108:Polymers / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects*; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology*
D011108:Polymers; D000804:Angiotensin II; D001464:Barium; D012701:Serotonin; D003189:p-Methoxy-N-methylphenethylamine; D010121:Oxytocin; D000109:Acetylcholine; D001920:Bradykinin